PeptidePedia The community reference

Contributions of Chromatokid

User contributions·124 logged edits·page 1 of 2

Contributions by Chromatokid, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 41,208 edits includes activity predating the current log.

  1. 10:03, 12 Jul 2026 (diff | hist) Sharps disposal 20,876 +59 add short description
  2. 13:19, 6 Jul 2026 (diff | hist) Sangon Biotech 12,025 ±0 British spelling per PP:MOS
  3. 04:49, 13 Jun 2026 (diff | hist) Sangon Biotech 12,025 ±0 m move table to the section it supports
  4. 22:11, 10 Jun 2026 (diff | hist) Zhuhai Kerui Biotechnology 12,118 ±0 add citation
  5. 11:16, 6 Jun 2026 (diff | hist) Hubei Jianxiang Bioscience 12,122 ±0 m update infobox
  6. 04:09, 3 Jun 2026 (diff | hist) Qingdao Saber Technology Pharmaceutical 11,956 ±0 correct molar mass
  7. 17:52, 25 May 2026 (diff | hist) Vial 26,012 ±0 tag [citation needed]
  8. 02:48, 25 May 2026 (diff | hist) ChinaPeptides 12,304 ±0 m convert prose to table for comparability
  9. 05:16, 10 May 2026 (diff | hist) Shanghai Wibson Biotechnology 11,996 ±0 tag [citation needed]
  10. 14:43, 8 May 2026 (diff | hist) Sangon Biotech 12,025 ±0 replace primary source with the review
  11. 03:07, 2 May 2026 (diff | hist) Shanghai ERP Biotechnology 11,702 ±0 promote subsection to section
  12. 02:35, 26 Apr 2026 (diff | hist) Reconstitution calculator 8,662 ±0 attribute range as a review estimate per talk
  13. 20:43, 17 Apr 2026 (diff | hist) Shanghai ERP Biotechnology 11,702 ±0 state the assay for the reference interval
  14. 10:22, 15 Apr 2026 (diff | hist) Talk:Glucose-dependent insulinotropic polypeptide 400 +241 /* GIP-incompetence: sourcing and terminology */ new section
  15. 14:22, 12 Apr 2026 (diff | hist) Talk:Enteroendocrine L cell 611 +174 /* L-cell regeneration timescale — sourced? */ reply
  16. 08:46, 12 Apr 2026 (diff | hist) Tianjin Finder Chemical 11,889 ±0 convert list to prose
  17. 13:19, 3 Apr 2026 (diff | hist) Chinese Peptide Company 12,627 ±0 add hatnote
  18. 02:14, 3 Apr 2026 (diff | hist) Nantong Guangyuan Chemical 12,306 ±0 m British spelling per PP:MOS
  19. 06:23, 26 Mar 2026 (diff | hist) Chinese Peptide Company 12,627 ±0 restructure
  20. 10:25, 22 Mar 2026 (diff | hist) Karl Fischer titration 9,318 ±0 correct molar mass
  21. 20:22, 12 Mar 2026 (diff | hist) Vial 26,012 ±0 m reorder sections to follow the class template
  22. 08:55, 12 Mar 2026 (diff | hist) GL Biochem (Shanghai) 13,879 ±0 m rv promotional edit
  23. 07:21, 27 Feb 2026 (diff | hist) Insulin syringe unit conversion 6,290 ±0 rm citation to a supplier's own page
  24. 05:37, 26 Feb 2026 (diff | hist) Temperature excursion 24,639 ±0 add PMID
  25. 02:19, 21 Feb 2026 (diff | hist) Glucose-dependent insulinotropic polypeptide 8,265 ±0 update infobox
  26. 05:45, 11 Feb 2026 (diff | hist) Zhuhai Kerui Biotechnology 11,932 ±0 fix unit
  27. 10:56, 5 Feb 2026 (diff | hist) Talk:Karl Fischer titration 959 +102 /* Cysteine interference needs a source */ reply
  28. 10:04, 5 Feb 2026 (diff | hist) Reconstitution calculator 8,662 ±0 m replace bare ref with full citation
  29. 09:55, 24 Jan 2026 (diff | hist) Cold chain 27,220 +70 m cite the trial publication rather than the press release
  30. 15:30, 22 Jan 2026 (diff | hist) Talk:Enteroendocrine L cell 1,022 +270 /* Should this article cover L-cell-derived peptides beyond GLP-1? */ reply
  31. 14:45, 22 Jan 2026 (diff | hist) Reconstitution calculator 8,662 ±0 rv addition of price information per PP:VN
  32. 10:35, 19 Jan 2026 (diff | hist) Karl Fischer titration 9,318 ±0 replace primary source with the review
  33. 02:10, 15 Jan 2026 (diff | hist) Nantong Guangyuan Chemical 12,306 ±0 m replace primary source with the review
  34. 22:47, 13 Jan 2026 (diff | hist) Cold chain 27,150 ±0 add table
  35. 14:36, 8 Jan 2026 (diff | hist) Talk:Qingdao Saber Technology Pharmaceutical 748 +370 /* One dissolution report — undue weight? */ reply
  36. 12:05, 4 Jan 2026 (diff | hist) Hubei Jianxiang Bioscience 11,936 ±0 consistent en dashes in ranges
  37. 22:11, 23 Dec 2025 (diff | hist) Vial 25,946 ±0 add confidence interval
  38. 21:50, 19 Dec 2025 (diff | hist) Chinese Peptide Company 12,627 ±0 m fix unit
  39. 10:20, 8 Dec 2025 (diff | hist) Talk:Temperature excursion 1,518 +309 /* Is a community-reported stability observation usable evidence at all? */ reply
  40. 12:55, 4 Dec 2025 (diff | hist) Talk:Peptide stability table 748 +339 /* Should extrapolated rows be in the table at all? */ reply
  41. 19:07, 1 Dec 2025 (diff | hist) Shanghai ERP Biotechnology 8,458 +783 label community tally as self-reported
  42. 08:09, 1 Dec 2025 (diff | hist) Tianjin Finder Chemical 11,703 ±0 hedge overclaim
  43. 22:05, 29 Nov 2025 (diff | hist) Flourishglobal Peptide Biotech 11,843 +226 typo
  44. 12:17, 21 Nov 2025 (diff | hist) Karl Fischer titration 9,318 ±0 add confidence interval
  45. 07:55, 20 Nov 2025 (diff | hist) Talk:Glucagon-like peptide-1 885 +147 /* Is the "50–75% degraded before leaving the gut" figure attributable? */ reply
  46. 12:40, 10 Nov 2025 (diff | hist) Reconstitution calculator 8,662 ±0 m add figure
  47. 23:59, 8 Nov 2025 (diff | hist) Syringe dead space 10,426 +234 rv promotional edit
  48. 09:18, 7 Nov 2025 (diff | hist) Talk:Bachem Holding (Suzhou) 959 +116 /* Purity without a reference standard */ reply
  49. 22:43, 1 Nov 2025 (diff | hist) ChinaPeptides 12,118 +65 m state the assay for the reference interval
  50. 09:10, 25 Oct 2025 (diff | hist) Chinese Peptide Company 12,441 ±0 split section
  51. 01:46, 12 Oct 2025 (diff | hist) Sangon Biotech 11,780 +226 rv addition of price information per PP:VN
  52. 22:55, 10 Oct 2025 (diff | hist) Shanghai Sigma-Audley New Material Technology 11,769 +798 m copyedit
  53. 11:40, 7 Oct 2025 (diff | hist) Trial data comparison 6,666 ±0 add see also
  54. 03:40, 6 Oct 2025 (diff | hist) Karl Fischer titration 9,318 ±0 m hedge overclaim
  55. 12:14, 27 Sep 2025 (diff | hist) Glucose-dependent insulinotropic polypeptide 8,265 ±0 label community tally as self-reported
  56. 11:27, 22 Sep 2025 (diff | hist) Sangon Biotech 10,912 ±0 m rm citation to a supplier's own page
  57. 03:53, 22 Sep 2025 (diff | hist) Glucagon-like peptide-1 12,102 ±0 m add PMID
  58. 16:35, 17 Sep 2025 (diff | hist) Talk:WuXi TIDES 748 +271 /* Is "agreement with the certificate" worth reporting? */ reply
  59. 18:31, 16 Sep 2025 (diff | hist) ChinaPeptides 11,373 +226 de-orphan
  60. 10:40, 13 Sep 2025 (diff | hist) Zhuhai Kerui Biotechnology 7,444 +417 m ce, tighten prose
  61. 11:42, 10 Sep 2025 (diff | hist) Syringe dead space 2,598 +780 add confidence interval
  62. 16:15, 9 Sep 2025 (diff | hist) Syringe dead space 1,818 ±0 consistent en dashes in ranges
  63. 01:44, 26 Aug 2025 (diff | hist) Flourishglobal Peptide Biotech 7,888 ±0 fix significant figures — source gives fewer
  64. 09:58, 20 Aug 2025 (diff | hist) Talk:Xi'an Mokemei Biotechnology 959 +198 /* Extract-derived listings need their own treatment */ reply
  65. 14:02, 12 Aug 2025 (diff | hist) WuXi TIDES 11,140 ±0 m update infobox
  66. 06:26, 12 Aug 2025 (diff | hist) Vial 22,966 +522 consistent en dashes in ranges
  67. 13:58, 20 Jul 2025 (diff | hist) Talk:Shanghai ERP Biotechnology 611 +168 /* Verifiability when the name is unsearchable */ reply
  68. 14:52, 14 Jul 2025 (diff | hist) Talk:Shanghai Sigma-Audley New Material Technology 748 +286 /* Documentation gradient across the catalogue */ reply
  69. 19:06, 6 Jul 2025 (diff | hist) Shanghai Sigma-Audley New Material Technology 8,674 ±0 restructure
  70. 08:31, 4 Jul 2025 (diff | hist) Peptide stability table 5,122 ±0 convert prose to table for comparability
  71. 22:19, 3 Jul 2025 (diff | hist) Guangzhou JEEP Biotechnology 11,169 ±0 expand §Operations and documentation practice
  72. 03:57, 29 Jun 2025 (diff | hist) Qingdao Sigma Chemical 10,152 ±0 rm unsourced claim per PP:V
  73. 18:58, 27 Jun 2025 (diff | hist) Qingdao Saber Technology Pharmaceutical 2,486 ±0 add hatnote
  74. 02:42, 27 Jun 2025 (diff | hist) Insulin syringe unit conversion 5,079 ±0 rv restoration of unsourced claim
  75. 16:15, 12 Jun 2025 (diff | hist) Trial data comparison 4,925 ±0 m add confidence interval
  76. 07:44, 7 Jun 2025 (diff | hist) Zhuhai Kerui Biotechnology 2,511 ±0 m correct molar mass
  77. 01:08, 6 Jun 2025 (diff | hist) Beyond-use date 14,717 +1,045 add see also
  78. 02:36, 21 May 2025 (diff | hist) Reconstitution calculator 6,980 ±0 expand §The calculator
  79. 11:27, 15 May 2025 (diff | hist) Xi'an Mokemei Biotechnology 5,169 +333 m attribute range as a review estimate per talk
  80. 09:03, 15 May 2025 (diff | hist) Talk:Reconstitution calculator 959 +209 /* Should the default vial mass be the gross or net figure? */ reply
  81. 17:02, 8 May 2025 (diff | hist) Sangon Biotech 7,279 +398 m fix arithmetic in worked example
  82. 12:05, 8 May 2025 (diff | hist) WuXi TIDES 9,852 ±0 m clarify whether figure is gross or net mass
  83. 08:56, 21 Apr 2025 (diff | hist) GL Biochem (Shanghai) 11,870 +207 add table
  84. 10:54, 17 Apr 2025 (diff | hist) Hubei Jianxiang Bioscience 2,205 +38 ce, tighten prose
  85. 07:44, 17 Apr 2025 (diff | hist) Trial data comparison 4,023 +157 split section
  86. 02:24, 27 Mar 2025 (diff | hist) Lyophilisation 19,880 +2,221 fix category — parent was wrong
  87. 23:44, 25 Mar 2025 (diff | hist) Beyond-use date 12,555 +461 m rm maintenance tag, addressed
  88. 13:00, 25 Mar 2025 (diff | hist) Insulin syringe unit conversion 3,664 ±0 ce, tighten prose
  89. 10:09, 18 Mar 2025 (diff | hist) Qingdao Sigma Chemical 7,945 ±0 add citation
  90. 06:09, 14 Mar 2025 (diff | hist) Shanghai Wibson Biotechnology 5,001 ±0 add DOI
  91. 06:42, 22 Feb 2025 (diff | hist) Peptide stability table 3,601 ±0 British spelling per PP:MOS
  92. 04:55, 20 Feb 2025 (diff | hist) Cold chain 18,768 +285 fix category — parent was wrong
  93. 00:02, 20 Feb 2025 (diff | hist) Vial 17,729 +578 rv restoration of unsourced claim
  94. 17:33, 15 Feb 2025 (diff | hist) WuXi TIDES 8,353 ±0 tag [citation needed]
  95. 08:28, 5 Feb 2025 (diff | hist) ChinaPeptides 6,092 +29 copyedit
  96. 20:46, 3 Feb 2025 (diff | hist) Bachem Holding (Suzhou) 6,584 +526 British spelling per PP:MOS
  97. 00:33, 19 Jan 2025 (diff | hist) Wuhan Wansheng Biotechnology 7,515 +92 add figure
  98. 05:43, 11 Jan 2025 (diff | hist) Cold chain 17,670 +74 add citation for the incidence figure
  99. 13:26, 5 Jan 2025 (diff | hist) Guangzhou JEEP Biotechnology 7,782 ±0 split overlong sentence
  100. 05:41, 29 Dec 2024 (diff | hist) Trial data comparison 1,546 +32 m typo